Ergoteles’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-299,584
Closed -$5.98M 2169
2022
Q3
$5.98M Buy
299,584
+208,984
+231% +$2.76M 0.21% 96
2022
Q2
$624K Buy
90,600
+57,600
+175% +$404K 0.02% 742
2022
Q1
$307K Buy
+33,000
New +$351K 0.01% 827

Ergoteles's FMTX Position: Q4 2022 in Review

Ergoteles sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 299,584 shares — an estimated $5.98M sold.

Ergoteles first reported a position in FMTX in Q1 2022 and held it in 3 quarters. The position peaked at $5.98M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • Ergoteles reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 299,584 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $5.98M.
  • Ergoteles first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q1 2022 and held it in 3 quarters.
  • Ergoteles's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $5.98M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.